Mass. device makers are hit hard by regulatory changes, recession

10/11/2010 | Mass High Tech (Boston)

The lengthy economic downturn has taken its toll on three Massachusetts-based medical device firms -- NMT Medical, AdvanSource Biomaterials and NeuroMetrix -- that have been warned of possible delisting from large stock exchanges. Changes in the regulatory environment, including Medicare reimbursement cuts, also are putting some pressure on these companies.

View Full Article in:

Mass High Tech (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR